Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Buxton

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|April 11, 2013
A quantitative high-throughput endothelial cell migration assayVladimir Mastyugin, Elizabeth McWhinnie, Mark Labow, et al.
Journal of Biomolecular Screening|January 7, 2005
A quantitative high-throughput endothelial cell migration assayVladimir Mastyugin, Elizabeth McWhinnie, Mark Labow, et al.
Journal of Biomolecular Screening|April 17, 2007
Optimization procedure for small interfering RNA transfection in a 384-well formatJason Borawski, Alicia Lindeman, Frank Buxton, et al.
Novartis Foundation Symposium|May 7, 2002
Gene expression profiling of epothilone A-resistant cellsPeter Atadja, Yan Yan-Neale, Harry Towbin, et al.
Pain|January 26, 2007
Role of the cysteine protease cathepsin S in neuropathic hyperalgesiaJane Barclay, Anna K Clark, Pam Ganju, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersGregory R Hoffman, Rami Rahal, Frank Buxton, et al.
Cell|July 29, 2017
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi ScreeningE Robert McDonald, Antoine de Weck, Michael R Schlabach, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|April 11, 2013
A quantitative high-throughput endothelial cell migration assayVladimir Mastyugin, Elizabeth McWhinnie, Mark Labow, et al.
Journal of Biomolecular Screening|January 7, 2005
A quantitative high-throughput endothelial cell migration assayVladimir Mastyugin, Elizabeth McWhinnie, Mark Labow, et al.
Journal of Biomolecular Screening|April 17, 2007
Optimization procedure for small interfering RNA transfection in a 384-well formatJason Borawski, Alicia Lindeman, Frank Buxton, et al.
Novartis Foundation Symposium|May 7, 2002
Gene expression profiling of epothilone A-resistant cellsPeter Atadja, Yan Yan-Neale, Harry Towbin, et al.
Pain|January 26, 2007
Role of the cysteine protease cathepsin S in neuropathic hyperalgesiaJane Barclay, Anna K Clark, Pam Ganju, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2014
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancersGregory R Hoffman, Rami Rahal, Frank Buxton, et al.
Cell|July 29, 2017
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi ScreeningE Robert McDonald, Antoine de Weck, Michael R Schlabach, et al.
Pageof 1